Create comprehensive study notes by integrating the latest editions of Guyton & Hall Textbook of Medical Physiology and Robbins & Cotran Pathologic Basis of Disease. Module: Cardiovascular System Physiology source: Include all relevant chapters from Guyton & Hall covering anatomy review (if needed for understanding), cardiac muscle physiology, electrical activity, cardiac cycle, ECG, hemodynamics, microcirculation, blood pressure regulation, coronary circulation, cardiac output, and cardiovascular regulation. Pathology source: Include all relevant chapters from Robbins & Cotran covering diseases of the heart and blood vessels such as ischemic heart disease, heart failure, valvular disease, cardiomyopathies, hypertension, atherosclerosis, aneurysms, vasculitis, thrombosis, embolism, shock, and vascular tumors. Prepare notes from basic to advanced including: Core concepts Definitions Normal physiology Cellular and molecular mechanisms Disease pathogenesis Morphological changes Clinical manifestations Investigations Flowcharts Tables Clinical correlations Important mechanisms High-yield facts Summary References to the relevant chapters from both books.

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File

CARDIOVASCULAR SYSTEM - Comprehensive Integrated Study Notes

Sources

  • Guyton and Hall Textbook of Medical Physiology (14th Ed, ISBN 9780443111013) - "Guyton"
  • Robbins, Cotran & Kumar Pathologic Basis of Disease (10th Ed, ISBN 9780443264528) - "Robbins"

PART I: PHYSIOLOGY (GUYTON & HALL)


MODULE 1: CARDIAC MUSCLE PHYSIOLOGY

1.1 Core Anatomy of the Heart

The heart has three major muscle types:
  1. Atrial muscle - contractions pump blood into ventricles
  2. Ventricular muscle - provides the major pumping force
  3. Specialized excitatory/conductive fibers - contain few contractile fibrils; generate and conduct action potentials
Guyton, Ch. 9 (Block 1, line 3572)

1.2 Structural Features of Cardiac Muscle

FeatureDetail
StriationsPresent (actin + myosin, like skeletal muscle)
Cell arrangementLatticework - fibers divide, recombine, and spread
Intercalated discsCell membranes between individual cells; contain gap junctions
Gap junctionsAllow rapid ion diffusion - cardiac muscle is a functional syncytium
Cell diameter10-15 μm (atrial/ventricular); 3-5 μm (nodal fibers)
Functional Syncytium: Because ions diffuse rapidly through gap junctions, the action potential spreads throughout all connected fibers simultaneously. The atria form one syncytium; the ventricles form another. They are separated by the fibrous AV ring (annulus fibrosus).
Left Ventricular Torsion (Twist):
  • Subepicardial fibers spiral leftward; subendocardial fibers spiral rightward (double helix)
  • During systole: apex rotates counterclockwise, base rotates clockwise (viewed from apex)
  • Creates a "wringing" motion - maximizes ejection efficiency
  • At end-systole, LV acts as a loaded spring; untwists during diastole to facilitate rapid filling
Guyton, Ch. 9 (Block 1, lines 3575-3613)

1.3 Action Potential of Cardiac Muscle

VENTRICULAR MUSCLE ACTION POTENTIAL
Phase 0 (Rapid depolarization): Fast Na⁺ channels open → rapid Na⁺ influx → membrane potential 
                                  rises from -90 mV to +20 mV
Phase 1 (Early repolarization): Fast Na⁺ channels close; transient K⁺ outward current (Ito)
Phase 2 (Plateau): L-type Ca²⁺ channels open (slow Ca²⁺-Na⁺ channels) → sustained Ca²⁺ influx 
                   balances K⁺ efflux → UNIQUE to cardiac muscle (lasts ~0.3 sec)
Phase 3 (Rapid repolarization): Ca²⁺ channels close; K⁺ channels (IKr, IKs) open → 
                                  K⁺ efflux repolarizes membrane
Phase 4 (Resting potential): -85 to -90 mV in ventricular cells
Key Difference from Skeletal Muscle: The plateau (Phase 2) is caused by slow Ca²⁺-Na⁺ channel activation and lasts ~0.3 seconds. This prolongs the action potential and prevents tetanic contraction (physiologically essential for pumping).
Refractory Period:
  • Absolute refractory period: ~0.25-0.3 sec - virtually the entire period of systole
  • Relative refractory period: ~0.05 sec after
  • Prevents summation and tetanus - the heart MUST relax between beats to fill

1.4 Excitation-Contraction Coupling

Action potential → T-tubule depolarization
        ↓
L-type Ca²⁺ channels open on T-tubule membrane
        ↓
Ca²⁺ entry triggers Ca²⁺-induced Ca²⁺ release (CICR) from SR via ryanodine receptors (RyR2)
        ↓
Cytosolic Ca²⁺ rises 100-fold (10⁻⁷ → 10⁻⁵ mol/L)
        ↓
Ca²⁺ binds troponin C → conformational change in troponin-tropomyosin complex
        ↓
Tropomyosin moves off actin binding sites
        ↓
Myosin heads attach to actin (cross-bridge formation) → Power stroke → Contraction
        ↓
Relaxation: Ca²⁺ pumped back into SR (SERCA2a, stimulated by phospholamban) 
           + expelled via Na⁺-Ca²⁺ exchanger (NCX)
Frank-Starling Law: Increased stretch of myocytes increases cross-bridge overlap, increasing force of contraction. More venous return → more stretch → stronger contraction → greater stroke volume. This is the intrinsic mechanism by which the heart pumps exactly the blood it receives.

MODULE 2: ELECTRICAL ACTIVITY OF THE HEART

2.1 Cardiac Conduction System

SA Node (pacemaker, 60-100 bpm)
      ↓ (internodal pathways + Bachmann's bundle)
AV Node (delay 0.1-0.12 sec)
      ↓
Bundle of His
      ↓ ↓
Left Bundle Branch    Right Bundle Branch
      ↓                       ↓
Left anterior/posterior      Right ventricular
fascicles                    Purkinje fibers
      ↓
Ventricular muscle (endocardium → epicardium)
Guyton, Ch. 10 (Block 2, lines 341-370)

2.2 SA Node - The Natural Pacemaker

Location: Superior posterolateral wall of the right atrium, inferior and lateral to the superior vena cava opening. Size: 3 mm wide, 15 mm long, 1 mm thick.
Intrinsic rhythm: 60-100 bpm. Overrides all subsidiary pacemakers (AV node 40-60 bpm; Purkinje fibers 15-40 bpm) because it depolarizes fastest.
Mechanism of Automaticity (Pacemaker Potential):
  • Resting membrane potential is only -55 to -60 mV (vs. -90 mV in ventricles) because the cell membrane is "leaky" to Na⁺ and Ca²⁺
  • If (funny current): Hyperpolarization-activated Na⁺ current → slow spontaneous depolarization (Phase 4)
  • When threshold (~-40 mV) is reached: L-type Ca²⁺ channels open → upstroke (no fast Na⁺ channels in nodal cells)
  • Repolarization: K⁺ channels open
Autonomic Modulation:
EffectSNS (NE/Epi)PNS (ACh)
Rate (chronotropy)↑ (If current ↑)↓ (IKACh ↑)
Contractility (inotropy)↓ (atria only)
Conduction velocity↓ (AV node)

2.3 The Electrocardiogram (ECG)

Wave/IntervalOriginNormal Duration
P waveAtrial depolarization0.06-0.12 sec
PR intervalAtrial depol + AV node delay0.12-0.20 sec
QRS complexVentricular depolarization<0.12 sec
ST segmentPlateau of ventricular action potentialIsoelectric (no net current)
T waveVentricular repolarization-
QT intervalVentricular depolarization + repolarization0.35-0.44 sec
High-Yield ECG Clues:
  • ST elevation → acute transmural ischemia/STEMI (injury current from ischemic cells)
  • ST depression → subendocardial ischemia / NSTEMI
  • T wave inversion → myocardial ischemia, ventricular hypertrophy
  • Wide QRS (>0.12 sec) → bundle branch block, ventricular rhythm
  • Prolonged PR → first-degree AV block
  • Delta wave + short PR → Wolff-Parkinson-White (accessory pathway)

MODULE 3: THE CARDIAC CYCLE

Guyton, Ch. 9 (Block 1, lines 3707-3727)

3.1 Phases of the Cardiac Cycle (Heart Rate 72 bpm = 0.83 sec/cycle)

DIASTOLE (≈0.5 sec total)
├── Isovolumetric relaxation: All valves closed; ventricle relaxes → pressure falls
├── Rapid ventricular filling (70%): Mitral/tricuspid open when LV pressure < LA pressure
├── Slow filling (diastasis): Blood trickles in
└── Atrial systole ("atrial kick"): Adds 20-30% of filling; ESSENTIAL at high heart rates

SYSTOLE (≈0.3 sec)
├── Isovolumetric contraction: All valves closed; LV pressure rises rapidly
├── Rapid ejection: Aortic valve opens when LV > Aortic pressure; fast SV ejected
└── Reduced ejection: Slower ejection; LV begins to relax

3.2 Pressure-Volume Relationships

ParameterNormal Value
End-diastolic volume (EDV)~120 mL
End-systolic volume (ESV)~50 mL
Stroke volume (SV)~70 mL (EDV - ESV)
Ejection fraction (EF)~60% (SV/EDV × 100)
Cardiac output (CO)~5 L/min (HR × SV)
Heart Sounds:
  • S1 ("lub"): Closure of mitral + tricuspid valves at start of systole
  • S2 ("dub"): Closure of aortic + pulmonary valves at end of systole
  • S3 (ventricular gallop): Rapid ventricular filling; normal in young; pathological in heart failure
  • S4 (atrial gallop): Atrial contraction against stiff ventricle; seen in LVH, diastolic dysfunction
Effect of Increased Heart Rate: At very high HR, diastole shortens disproportionately → incomplete filling → reduced CO. This is why tachyarrhythmias can cause hemodynamic compromise.

MODULE 4: HEMODYNAMICS AND CARDIAC OUTPUT

4.1 Key Hemodynamic Equations

ParameterFormulaNormal
Cardiac OutputCO = HR × SV4-8 L/min
Cardiac IndexCI = CO / BSA2.5-4 L/min/m²
Mean Arterial PressureMAP = DBP + 1/3(PP)70-100 mmHg
Pulse PressurePP = SBP - DBP~40 mmHg
Total Peripheral ResistanceTPR = MAP / CO~1200 dyne·sec/cm⁵
Ohm's LawFlow = ΔP / R-
Poiseuille's LawR = 8ηL / πr⁴Radius is dominant factor
Key Insight (Poiseuille): Resistance varies inversely with the 4th power of the radius. Halving the vessel radius increases resistance 16-fold. This makes arteriolar caliber the most powerful regulator of blood flow.

4.2 Frank-Starling Mechanism and Venous Return

Guyton, Ch. 20 (Block 3, lines 379-414)
  • Venous return is the primary controller of cardiac output under normal conditions
  • The heart has a built-in mechanism to pump whatever blood arrives (Frank-Starling)
  • Mean circulatory filling pressure (MCFP): ~7 mmHg - the pressure that drives venous return when the heart stops
  • Cardiac output curve: CO rises as right atrial pressure increases (Starling mechanism)
  • Venous return curve: VR falls as right atrial pressure increases (less pressure gradient)
  • Equilibrium point: Intersection of CO and VR curves = actual cardiac output
Factors Increasing CO:
  • Increased blood volume (↑ MCFP → ↑ venous return)
  • Sympathetic stimulation (↑ contractility + ↑ HR)
  • Exercise (muscle pump, ↓ resistance, ↑ metabolic vasodilation)
  • Hyperthyroidism, AV fistulas, Paget's disease, anemia (high-output states)

MODULE 5: BLOOD PRESSURE REGULATION

5.1 Short-Term Regulation

Baroreceptor Reflex (Most Important):
↑ Arterial BP
     ↓
Carotid sinus + aortic arch baroreceptors (stretch) → ↑ afferent impulses to NTS (medulla)
     ↓
↑ Vagal tone → ↓ HR (negative chronotropy)
↓ Sympathetic tone → ↓ HR, ↓ contractility, ↓ vasomotor tone → vasodilation
     ↓
↓ CO + ↓ TPR → BP normalizes
  • Responds within seconds; resets over days with sustained hypertension (explains why it doesn't cure chronic HTN)
Other Short-Term Mechanisms:
  • Chemoreceptor reflex (peripheral: carotid + aortic bodies; central: medullary)
  • CNS ischemic response (Cushing response: last resort - activated when ICP rises)
  • Stress relaxation of vessels

5.2 Long-Term Regulation - Pressure-Natriuresis

↑ Arterial BP
     ↓
↑ Renal perfusion pressure
     ↓
↑ Urinary Na⁺ and water excretion (pressure-natriuresis)
     ↓
↓ Blood volume → ↓ CO → ↓ BP
This system is infinitely gain - the kidneys can always bring BP back to normal as long as they function. Hypertension requires either a kidney defect or excess hormonal influence on the kidneys.
RAAS Axis:
↓ Renal perfusion / ↓ Na⁺ delivery to macula densa / ↑ SNS
        ↓
Juxtaglomerular cells release RENIN
        ↓
Angiotensinogen → Angiotensin I (ACE, lung) → Angiotensin II
        ↓
• Vasoconstriction (AT1 receptor)
• Aldosterone release (↑ Na⁺ + H₂O retention)
• ADH release (↑ water retention)
• Sympathetic activation
• Cardiac/vascular hypertrophy (remodeling)

MODULE 6: CORONARY CIRCULATION

Guyton, Ch. (Block 3, lines 1017-1055)

6.1 Anatomy

  • Left coronary artery (LCA): Divides into LAD (anterior wall, septum) + LCx (lateral wall)
  • Right coronary artery (RCA): Supplies RA, RV, inferior LV, SA node (in 60%), AV node (in 85%)
  • Normal coronary blood flow: ~250 mL/min = ~5% of cardiac output
  • Coronary flow mainly occurs in diastole (systolic compression of intramyocardial vessels)
  • Subendocardium is most vulnerable to ischemia (highest wall tension, lowest perfusion pressure)

6.2 Autoregulation and Control

MechanismEffect
Metabolic autoregulationAdenosine, CO₂, K⁺, H⁺ from ischemic tissue → vasodilation
Myogenic autoregulationVessel maintains flow despite pressure changes (50-150 mmHg range)
Endothelial NOcGMP → vasodilation (blocked in atherosclerosis)
SympatheticAlpha → vasoconstriction; Beta₂ → vasodilation (metabolic effect dominates)
Coronary Flow Reserve: The ratio of maximal vasodilated flow to resting flow (~4-5x). Critical stenosis (>70% lumen narrowing) impairs flow reserve, limiting response to exercise.

MODULE 7: MICROCIRCULATION AND LYMPHATICS

  • Capillary exchange: Starling forces govern fluid movement
    • Filtration forces: Capillary hydrostatic pressure (Pc) + interstitial oncotic pressure (πi)
    • Reabsorption forces: Plasma oncotic pressure (πp) + interstitial hydrostatic pressure (Pi)
  • Net filtration pressure = (Pc + πi) - (πp + Pi)
  • Slightly more fluid filters than is reabsorbed → lymphatics return excess ~2-4 L/day
  • Edema = filtration > reabsorption + lymphatic capacity
    • Increased Pc (↑ venous pressure, heart failure)
    • Decreased πp (hypoalbuminemia)
    • Increased capillary permeability (inflammation)
    • Lymphatic obstruction (lymphedema)


PART II: PATHOLOGY (ROBBINS & COTRAN)


MODULE 8: ATHEROSCLEROSIS

Robbins, Ch. 11 (Block 5, lines 2764-3058)

8.1 Definition and Epidemiology

Atherosclerosis is an intimal-based lesion composed of a fibrous cap and atheromatous (lipid-rich) core affecting elastic arteries (aorta, carotids) and large/medium muscular arteries (coronaries, iliacs).
  • Responsible for ~50% of deaths in Western world
  • Leading cause globally: coronary artery disease → MI, sudden death
  • Death rate from CAD in Eastern Europe is 7-12x higher than Japan

8.2 Risk Factors

Nonmodifiable (Constitutional)Modifiable
Genetic variation / Family historyHyperlipidemia (↑ LDL, ↓ HDL)
Increasing ageHypertension
Male sex (premenopausal females protected by estrogen)Cigarette smoking
Diabetes mellitus
Obesity / metabolic syndrome
C-reactive protein / inflammation markers
Homocysteinemia
Most important independent risk factor: FAMILY HISTORY

8.3 Pathogenesis - Response-to-Injury Hypothesis

STEP 1: ENDOTHELIAL INJURY / DYSFUNCTION
• Risk factors (HTN, hyperlipidemia, smoking, diabetes) cause endothelial activation
• ↓ Nitric oxide production → vasoconstriction, platelet aggregation
• ↑ Permeability + ↑ adhesion molecule expression (VCAM-1, ICAM-1, E-selectin)

STEP 2: LIPID ACCUMULATION IN INTIMA
• LDL enters and becomes oxidized (oxLDL) in the intima
• oxLDL is proinflammatory and cytotoxic to endothelium/SMCs
• "Fatty streak" (earliest lesion): flat, lipid-filled macrophages (foam cells) in intima
  → Appears in aorta as early as age 10

STEP 3: MONOCYTE RECRUITMENT AND FOAM CELL FORMATION
• Monocytes adhere to EC, transmigrate into intima, differentiate to macrophages
• Macrophages take up oxLDL via scavenger receptors (SR-A, CD36) → FOAM CELLS
• Foam cells secrete cytokines (TNF, IL-1, IL-6) → amplify inflammation

STEP 4: SMC MIGRATION AND PROLIFERATION
• Growth factors (PDGF, FGF from platelets, macrophages) → SMC migration from media to intima
• SMCs produce ECM (collagen, proteoglycans) → fibrous cap formation
• SMC proliferation + ECM = the fibrous cap

STEP 5: PLAQUE EVOLUTION
• Fibrous plaque: Central lipid/necrotic core + fibrous cap (collagen, SMCs, T cells)
• Calcification, hemorrhage, necrosis → complex (advanced) plaque

8.4 Stable vs. Vulnerable (Unstable) Plaques

FeatureStable PlaqueVulnerable Plaque
Fibrous capThickThin
Lipid coreSmallLarge
InflammationMinimalDense (macrophages, T cells)
MMPsLowHigh (degrade cap collagen)
RiskGradual stenosisRupture → thrombosis → ACS
StenosisOften >70%Often <50%
Key Insight: Most MIs occur from rupture of a plaque that did NOT cause critical stenosis (i.e., no prior angina). The "vulnerable plaque" concept explains why statin therapy reduces MI risk beyond just lowering cholesterol - it stabilizes plaque by reducing inflammation.

8.5 Complications of Atherosclerosis

  • Plaque rupture → acute thrombosis → MI, stroke
  • Plaque erosion (more common in women, diabetics) → thrombosis without rupture
  • Calcification → stenosis
  • Aneurysm formation (media ischemia from increased diffusion distance)
  • Embolism from mural thrombus

MODULE 9: ISCHEMIC HEART DISEASE (IHD)

Robbins, Ch. 12 (Block 6, lines 1077-1469)

9.1 Definition and Overview

IHD = a group of related entities resulting from myocardial ischemia (imbalance between O₂ supply and demand). >90% caused by coronary atherosclerosis. Also called Coronary Artery Disease (CAD).
IHD is the single largest cause of mortality worldwide (>15% of global deaths, ~9 million/year in high-resource countries).

9.2 Clinical Presentations of IHD

CORONARY ATHEROSCLEROSIS (slow, decades-long progression)
           ↓
     Plaque rupture / thrombosis
           ↓
   ┌────────────────────────────────────────────────────────┐
   │                                                          │
Stable Angina      Unstable Angina     Acute MI         Sudden Cardiac
(>70% fixed         (non-occlusive      (complete         Death
 stenosis;           mural thrombus;     occlusion;        (ventricular
 exertional          rest pain)          necrosis)         fibrillation)
 chest pain)
   └────────────────────────────────────────────────────────┘
                           ↓
              Chronic IHD / Heart Failure

9.3 Myocardial Infarction

Types:
STEMINSTEMI
Transmural (full-thickness)Subendocardial (partial)
Complete coronary occlusionIncomplete or transient occlusion
ST elevation on ECGST depression / T-wave changes
Total occlusion thrombusMural (non-occlusive) thrombus
Higher early mortalityOften multivessel disease
Most common locations:
  • LAD territory (40-50%): Anterior wall + apex + anterior septum
  • RCA territory (30-40%): Inferior + posterior LV
  • LCx territory (15-20%): Lateral LV wall
Pathogenesis of Ischemic Cell Injury:
Ischemia → ↓ O₂ → ↓ Oxidative phosphorylation → ↓ ATP
           → Switch to anaerobic glycolysis → lactic acidosis
           → Na⁺/K⁺-ATPase failure → ↑ intracellular Na⁺, Ca²⁺, water
           → Cell swelling → membrane blebbing
           
>20-30 minutes of ischemia → IRREVERSIBLE INJURY (point of no return)
           ↓
Lysosomal enzyme release + Ca²⁺ overload → myocyte necrosis (coagulative necrosis)

9.4 Morphologic Evolution of MI

Robbins, Table 12.5 (Block 6, lines 1286-1288)
TimeGrossLight MicroscopeElectron Microscope
0-0.5 hr (reversible)NoneNoneMitochondrial swelling; glycogen loss; myofibril relaxation
0.5-4 hrNoneVariable wavy fibers at borderSarcolemmal disruption; mitochondrial densities
4-12 hrDark mottlingEarly coagulative necrosis; edema; hemorrhage-
12-24 hrDark mottlingCoagulative necrosis; pyknotic nuclei; hypereosinophilia; contraction band necrosis; neutrophil infiltrate-
1-3 daysYellow-tan center with mottlingLoss of nuclei + striations; brisk neutrophil infiltrate-
3-7 daysHyperemic border; central yellow-tan softeningDisintegration of dead fibers; macrophage infiltration-
1-3 weeksYellow-tan with fibrovascular borderGranulation tissue replacing dead myocytes-
>2 monthsWhite, firm scarFibrous scar; minimal cellularity-
Useful trick: TTC (triphenyl tetrazolium chloride) staining - intact myocardium stains brick-red; infarcted (LDH-depleted) tissue is pale/unstained. Useful for recognizing early MI at autopsy.
Reperfusion Injury: Restoring blood flow after ischemia paradoxically causes additional damage via:
  • Reactive oxygen species (ROS) from re-energized cells + infiltrating neutrophils
  • Calcium overload
  • Mitochondrial permeability transition pore (mPTP) opening
  • Manifests as contraction band necrosis (hypercontracted sarcomeres), arrhythmias
Cardiac Biomarkers:
MarkerRisesPeaksReturns to NormalNotes
Troponin I / T3-6 hrs12-24 hrs (TnI), 12-48 hrs (TnT)7-10 daysGold standard; most sensitive/specific
CK-MB4-8 hrs24 hrs48-72 hrsUsed to detect reinfarction
Myoglobin1-4 hrs4-8 hrs24-48 hrsFirst to rise; non-specific
LDH24 hrs3-6 days8-14 daysHistorical; LDH1 > LDH2 flip

9.5 Complications of MI

EARLY (within hours-days):
• Arrhythmias (most common cause of death in first hour) - VF
• Cardiogenic shock (large MI >40% LV)
• Pericarditis (fibrinous, 2-4 days post-MI) → Dressler's syndrome (autoimmune, weeks later)

EARLY-INTERMEDIATE (days-2 weeks):
• Cardiac rupture:
  - Free wall rupture (1-3 days, 3-5 days most common) → hemopericardium → tamponade
  - Septal rupture → VSD → acute left-to-right shunt
  - Papillary muscle rupture → acute mitral regurgitation
  → All more common with FIRST MI, no prior infarction/scar

LATE (weeks-months):
• Ventricular aneurysm (mural - fibrous thin wall; contains thrombus)
• Mural thrombus (akinetic wall → stasis → emboli)
• Chronic heart failure (ischemic cardiomyopathy)

MODULE 10: HEART FAILURE

Robbins, Ch. 12 (Block 6, lines 635-774)

10.1 Definition

Heart failure = inability of the heart to pump blood to meet peripheral metabolic demands, or to do so only at elevated filling pressures. Affects >6.5 million Americans; ~400,000 deaths/year; 5-year mortality ~50%.

10.2 Compensatory Mechanisms (Initially Adaptive, Then Maladaptive)

Cardiac Injury / Overload
         ↓
1. Frank-Starling mechanism: ↑ EDV → ↑ stretch → ↑ contractile force
2. Neurohormonal activation:
   • SNS: ↑ NE → ↑ HR + contractility + vasoconstriction
   • RAAS: ↑ Angiotensin II + Aldosterone → Na⁺/water retention → ↑ preload
   • ADH: ↑ water retention
   • ANP/BNP: Counterregulatory (natriuresis, vasodilation) - elevated in CHF → useful biomarker
3. Cardiac hypertrophy and remodeling
         ↓
  (Over time → maladaptive)
• Neurohormonal overdrive → fibrosis, apoptosis, further dysfunction
• Pathologic hypertrophy → myocyte disorganization, fibrosis
• Ventricular dilation → geometric disadvantage (↓ efficiency per Laplace's law)
         ↓
         DECOMPENSATED HEART FAILURE

10.3 HFrEF vs. HFpEF

FeatureHFrEF (EF ≤40%)HFpEF (EF ≥50%)
MechanismSystolic dysfunction (↓ contractility)Diastolic dysfunction (↓ compliance)
PathologyDilated, thin-walled ventricleHypertrophied, stiff ventricle
CausePost-MI, DCM, myocarditisHTN, HCM, amyloidosis, aging
DemographicsYounger, maleOlder, female, obese, diabetic
BNP↑↑↑ (less)
TreatmentGDMT (ACEi, BB, MRA, SGLT2i)Limited proven treatments

10.4 Left-Sided Heart Failure

Robbins, Block 6, lines 711-747
Causes: Ischemic heart disease, hypertension, aortic/mitral valve disease, DCM
Morphology:
  • LV dilation and hypertrophy (eccentric or concentric depending on etiology)
  • LA dilation (pulmonary congestion)
  • Lungs: edema, "brawny induration" (chronic congestion), hemosiderin-laden macrophages ("heart failure cells") in alveolar spaces
Clinical Features:
  • Forward failure: ↓ CO → fatigue, weakness, ↓ exercise tolerance, renal hypoperfusion (prerenal azotemia), cool extremities
  • Backward failure: ↑ pulmonary venous pressure → pulmonary edema → dyspnea, orthopnea, PND, crackles

10.5 Right-Sided Heart Failure

Cause: Most often from left-sided heart failure (↑ pulmonary pressure → RV overload); also pulmonary HTN, COPD ("cor pulmonale"), RV infarction
Morphology: RV dilation and hypertrophy; hepatic congestion ("nutmeg liver" → cardiac cirrhosis); splenomegaly; edema
Clinical Features (Backward failure):
  • JVD (jugular venous distension)
  • Peripheral pitting edema (dependent)
  • Hepatomegaly, ascites
  • Anorexia, nausea (bowel congestion)

MODULE 11: CARDIOMYOPATHIES

Robbins, Ch. 12 (Block 6, lines 1966-2215)

11.1 Classification and Comparison

FeatureDilated (DCM)Hypertrophic (HCM)Restrictive (RCM)
VentricleDilated, thin wallHypertrophied (asymmetric septal), NOT dilatedNormal/slight hypertrophy; non-compliant
Dominant dysfunctionSystolic (↓ EF)Diastolic (poor compliance ± outflow obstruction)Diastolic (rigid wall)
GeneticsCytoskeletal proteins (TTN, LMNA, dystrophin) - AD, 50% casesSarcomeric proteins (MYH7, MYBP-C) - AD with variable penetranceAmyloid, sarcoid, hemochromatosis, Loeffler
Key mutationTitin (TTN) truncations = 10-20% DCMβ-MHC (MYH7) + MYBP-C = 70-80% HCMVaries by etiology
Echo↓ EF; dilated all 4 chambersHOCM with SAM; asymmetric septal hypertrophy↓ diastolic filling; "sparkling" myocardium (amyloid)
MicroscopyMyocyte hypertrophy + atrophy; interstitial fibrosis; scattered lymphocytesMyocardial disarray (disorganized bundles); interstitial fibrosisAmyloid deposition; granulomas (sarcoid)
Major riskSystolic heart failure; thromboemboliSudden cardiac death (young athletes); outflow obstructionProgressive heart failure
TreatmentGDMT (same as HFrEF); ICD; transplantSeptal myectomy / alcohol ablation; Mavacamten (myosin inhibitor)Treat underlying cause

11.2 DCM - Key Points

  • Progressive dilation + systolic dysfunction; ALL 4 chambers enlarged
  • 50% familial (mutations in cytoskeletal proteins: titin, lamin A/C, dystrophin, desmin)
  • Other causes: viral myocarditis (Coxsackie B), alcohol (direct toxicity + thiamine deficiency → beriberi), cobalt, chemotherapy (anthracyclines, trastuzumab), peripartum, HIV
  • Microscopy: hypertrophied + atrophied fibers; interstitial/perivascular fibrosis; vacuolar change; no necrosis (unless from ischemia)

11.3 HCM - Key Points

  • Prevalence 1 in 500 - most common genetic cardiovascular disease
  • AD with variable penetrance; gain-of-function mutations in sarcomeric proteins → hypercontractility
  • Classic: asymmetric septal hypertrophy + SAM (systolic anterior motion of mitral valve) → LVOTO
  • Microscopy: "myocardial disarray" (cardinal feature - disorganized bundles, chaotic myocyte arrangement) + interstitial fibrosis
  • Leading cause of sudden cardiac death in young athletes (arrhythmia from disarrayed myocytes)
  • Novel therapy: Mavacamten - allosteric inhibitor of cardiac myosin ATPase (reduces hypercontractility)

MODULE 12: VALVULAR HEART DISEASE

Robbins, Ch. 12 (Block 6, lines 1591-1665)

12.1 Overview

TypeMechanismMain Causes
Aortic stenosisCalcification/leaflet fixationDegenerative calcification (age >60); Bicuspid aortic valve (age 40-60); Rheumatic (rare in developed world)
Aortic regurgitationValve/aortic root failureAortic root dilation (HTN, aging, Marfan); Infective endocarditis; Bicuspid AV; Rheumatic
Mitral stenosisLeaflet fusion/scarringRheumatic heart disease (most common cause worldwide)
Mitral regurgitationValve/subvalvular failureMitral valve prolapse (myxomatous degeneration - most common in US); Ischemic (papillary muscle dysfunction); Infective endocarditis; Rheumatic
Mitral valve prolapseMyxomatous degenerationIdiopathic (2-3% population); Marfan syndrome; Ehlers-Danlos

12.2 Calcific Aortic Stenosis

Robbins, Block 6, lines 1618-1637
  • Most common valvular disease requiring surgery in developed world
  • Degenerative calcification of normally tricuspid valve (age >70) or congenitally bicuspid valve (age 40-60s)
  • Pathogenesis similar to atherosclerosis: lipid deposition, macrophage/lymphocyte infiltration, fibrosis, calcification
  • Symptoms (SAD triad): Syncope, Angina, Dyspnea (in order of increasing severity)
  • Once symptomatic: median survival - syncope 3 years, angina 5 years, dyspnea/CHF 2 years
  • Murmur: Systolic ejection murmur - harsh, crescendo-decrescendo, radiates to neck

12.3 Rheumatic Heart Disease

  • Follows streptococcal pharyngitis by 2-4 weeks
  • Autoimmune: molecular mimicry - anti-strep antibodies cross-react with cardiac antigens (M protein vs. cardiac myosin, valvular glycoproteins)
  • Acute Rheumatic Fever (Jones Criteria):
    • Major: Carditis, Polyarthritis, Chorea, Erythema marginatum, Subcutaneous nodules
    • Minor: Fever, elevated CRP/ESR, prolonged PR interval
  • Acute lesion: Aschoff bodies (granulomatous foci with fibrinoid necrosis, macrophages/Anitschkow cells "owl-eye" caterpillar cells, lymphocytes)
  • Verrucous endocarditis: Small fibrinous vegetations along valve leaflet lines of closure
  • Chronic: Fibrous thickening and fusion of leaflets + commissure fusion → mitral stenosis ("fish mouth" valve)

MODULE 13: HYPERTENSION AND HYPERTENSIVE HEART DISEASE

13.1 Hypertension

Definition: Sustained BP >130/80 mmHg (ACC/AHA 2017) - present in 1 billion people worldwide
TypeDescription%
Primary (essential)No identifiable cause; polygenic + environmental95%
SecondaryIdentifiable cause5%
Secondary HTN causes: Renal parenchymal disease, renovascular disease (renal artery stenosis), primary hyperaldosteronism (Conn's syndrome), pheochromocytoma, Cushing's syndrome, coarctation of aorta, OCP use
Pathogenesis of Primary HTN: Complex interaction of:
  • Genetic factors (dozens of alleles; affects Na⁺ handling, RAAS, SNS)
  • Increased Na⁺ retention → volume expansion (environmental: high-salt diet + genetic susceptibility)
  • RAAS overactivation
  • SNS overactivity
  • Endothelial dysfunction (↓ NO, ↑ ET-1)
  • Insulin resistance / metabolic syndrome

13.2 End-Organ Damage in Hypertension

OrganPathology
HeartLeft ventricular hypertrophy (LVH) → diastolic dysfunction → HFpEF → dilated ischemic HF; ↑ risk sudden death; ↑ risk MI
BrainLacunar infarcts, hypertensive encephalopathy, intracerebral hemorrhage (Charcot-Bouchard microaneurysms in basal ganglia), vascular dementia
KidneyHypertensive nephrosclerosis: arteriolar thickening (hyaline arteriolosclerosis) → ↓ GFR; Malignant HTN: fibrinoid necrosis of arterioles ("flea-bitten kidney")
EyesArteriovenous nicking, flame hemorrhages, cotton-wool spots, papilledema (malignant HTN)
ArteriesAccelerated atherosclerosis; aortic dissection

13.3 Hypertensive Heart Disease

Concentric LV Hypertrophy = adaptation to sustained pressure overload (↑ afterload)
  • Sarcomeres added in parallel → increased wall thickness without increase in cavity size
  • Initially compensatory → maintains systolic function
  • Over time → diastolic dysfunction (stiff ventricle) → HFpEF
  • Eventually systolic dysfunction as decompensation occurs → HFrEF
Eccentric Hypertrophy = response to volume overload (e.g., aortic regurgitation, DCM)
  • Sarcomeres added in series → cavity dilates + wall thins

MODULE 14: PERICARDIAL DISEASES

DiseaseCauseMorphologyClinical
Fibrinous pericarditisPost-MI (Dressler's), uremia, radiation"Bread-and-butter" surface; shaggy fibrinPleuritic chest pain; friction rub; Saddleback ST elevation
Serous pericarditisViral (Coxsackie, echovirus), SLE, RAPale yellow exudate; usually <30 mLMild chest pain; may have rub
Purulent/suppurativeBacterial (Staph, Strep, Pneumo)Turbid, thick exudateSepsis + chest pain
HemorrhagicTB, malignancy, traumaBlood + fibrinTamponade risk
Cardiac TamponadeRapid effusion >200 mLCompression of cardiac chambersBeck's triad: hypotension, JVD, muffled heart sounds; pulsus paradoxus
Constrictive pericarditisTB, post-viral, post-radiationFibrous, calcified pericardiumMimics right heart failure; Kussmaul's sign

MODULE 15: ANEURYSMS AND DISSECTION

Robbins, Ch. 11 (Block 5, lines 3061-3200)

15.1 Definitions

  • True aneurysm: Involves all three layers (intima, media, adventitia); e.g., atherosclerotic AAA, ventricular aneurysm post-MI
  • False aneurysm (pseudoaneurysm): Defect in wall → extravascular hematoma communicating with vessel; e.g., post-MI free-wall rupture contained by pericardium
  • Dissection: Blood enters defect in wall and tunnels through media; does NOT require prior aneurysm

15.2 Abdominal Aortic Aneurysm (AAA)

  • Most common location: Infrarenal aorta (between renal arteries and bifurcation)
  • Risk factors: Male sex (5:1), age >50, smoking, HTN, atherosclerosis
  • Size threshold for repair: ≥5.5 cm (risk of rupture increases exponentially)
  • Morphology: Severe atherosclerosis with medial destruction; mural thrombus; fusiform or saccular
  • Rupture risk: Abrupt onset tearing/ripping abdominal/back pain → hemorrhagic shock; mortality >80% if ruptured, ~5% for elective repair

15.3 Aortic Dissection

  • Most common life-threatening aortic catastrophe
  • Blood enters media through intimal tear → splits media longitudinally
  • Main risk factor: HYPERTENSION (>90%)
  • Also: Marfan syndrome (cystic medial degeneration → elastic fiber fragmentation), bicuspid AV, pregnancy, Ehlers-Danlos
  • Stanford Classification:
    • Type A: Involves ascending aorta (±descending) → emergency surgery
    • Type B: Only descending aorta (distal to L subclavian) → medical management initially
  • DeBakey Classification: Type I (entire aorta), Type II (ascending only), Type III (descending only)
  • Clinical: Sudden severe "tearing" or "ripping" chest pain radiating to back/abdomen; asymmetric pulses and BP in arms; aortic regurgitation murmur (Type A)
  • Complications: Cardiac tamponade (Type A), aortic regurgitation, coronary/brachiocephalic artery occlusion, spinal ischemia, renal/mesenteric ischemia

MODULE 16: VASCULITIS

Robbins, Ch. 11 (Block 5, lines 3246-3250)

16.1 Classification by Vessel Size

VasculitisVessel SizeKey FeaturesClassic Presentation
Giant Cell (Temporal) ArteritisLarge (temporal, ophthalmic, aorta)Granulomatous; CD4+ T cells; giant cells; skip lesionsAge >50; headache, scalp tenderness, jaw claudication, visual loss; ↑ ESR
Takayasu ArteritisLarge (aorta + branches)Granulomatous; "pulseless disease"Age <40 (female); diminished pulses; limb claudication; visual disturbances
Polyarteritis Nodosa (PAN)Medium (renal, hepatic, coronary)Segmental necrotizing; NOT associated with ANCA; associated with HBVFever, weight loss; renal failure; hypertension; abdominal pain; mononeuritis multiplex
Kawasaki DiseaseMedium (coronary arteries)Necrotizing inflammation + aneurysm formation<5 years old; fever >5 days; CRASH mnemonic; coronary aneurysms
Wegener's (GPA)Small (respiratory + renal)Granulomatous; c-ANCA (anti-PR3)Sinusitis, hemoptysis, glomerulonephritis; "saddle-nose deformity"
Churg-Strauss (EGPA)SmallGranulomatous + eosinophilic; p-ANCA (anti-MPO)Asthma + eosinophilia + vasculitis; cardiac involvement in 50%
Microscopic PolyangiitisSmall (capillaries)Non-granulomatous; p-ANCAPulmonary-renal syndrome
IgA Vasculitis (HSP)Small (IgA deposits)Immune complex mediatedChildren; palpable purpura + arthritis + GI pain + nephritis

MODULE 17: THROMBOSIS, EMBOLISM, AND INFARCTION

Robbins, Ch. 4 (Block 2, lines 296-570)

17.1 Virchow's Triad - Pathogenesis of Thrombosis

       THROMBOSIS
      ↗     ↑     ↖
Endothelial  Abnormal  Blood flow
 Injury     blood flow  abnormality
(exposure   (stasis or  (hypercoagulability)
of TF,       turbulence)
collagen)
Arterial thrombosis: Plaque rupture → platelet-rich "white thrombus" (primary, then secondary) Venous thrombosis (DVT): Stasis + hypercoagulability → fibrin-rich "red thrombus"
Hypercoagulable States:
InheritedAcquired
Factor V Leiden (most common; APC resistance)Immobilization
Prothrombin G20210APost-surgery
AT-III deficiencyMalignancy (Trousseau's)
Protein C/S deficiencyAntiphospholipid syndrome
Pregnancy/OCP
HIT

17.2 Embolism Types

TypeSourceKey Complications
Pulmonary embolismDVT (iliac, femoral, popliteal veins)Sudden dyspnea/pleuritic pain; saddle embolus → sudden death; smaller → infarction (hemorrhagic wedge-shaped pleural-based)
Systemic arterial embolismCardiac thrombus (LV post-MI, LA in AF); atheromaLimb ischemia, stroke, mesenteric ischemia, renal infarction
Fat embolismLong bone fractures, liposuctionPetechiae, neurological symptoms, hypoxemia (>24 hr post-trauma)
Air embolismIatrogenic IV, decompression sicknessGas lock in pulmonary arteries; "bends" (N₂ bubbles in joints, fat, CNS)
Amniotic fluid embolismLabor/deliveryDIC + respiratory failure; enters maternal veins

17.3 Shock

Robbins, Ch. 4 (Block 2, lines 651-756)
TypeMechanismHemodynamicsExamples
CardiogenicPump failure↓ CO, ↑ SVR, ↑ PCWPMassive MI, tamponade, massive PE
Hypovolemic↓ Blood/fluid volume↓ CO, ↑ SVR, ↓ CVPHemorrhage, burns, dehydration
Distributive (Septic)Vasodilation + maldistribution↓ SVR, ↑/normal CO, ↑ cardiac demandSepsis, anaphylaxis, neurogenic
ObstructiveOutflow obstruction↓ CO, ↑ SVRMassive PE, tension pneumothorax, tamponade
Stages of Shock:
  1. Compensated/Reversible: SNS activation → tachycardia, vasoconstriction, pallor, ↑ ADH/RAAS → oliguria. BP maintained.
  2. Progressive: Tissue hypoxia → anaerobic metabolism → lactic acidosis → cell injury. Compensatory mechanisms fail.
  3. Irreversible: Widespread cell death; vital organ failure; DIC; MODS; death.
Septic Shock - Pathogenesis:
Infection (gram +/-, fungi) → pattern recognition (TLRs) → macrophage activation
     ↓
Cytokine storm: TNF-α, IL-1, IL-6, IL-12 → massive vasodilation + ↑ permeability
     ↓
• iNOS overactivation → excess NO → refractory vasodilation
• Endothelial activation → DIC
• Mitochondrial dysfunction → energy failure
• Multi-organ dysfunction syndrome (MODS)

MODULE 18: VASCULAR TUMORS

TumorOriginBehaviorKey Features
HemangiomaBenign vascularBenignMost common benign tumor; capillary (skin) or cavernous (liver, brain) types; often regress in infancy
Pyogenic granulomaCapillary hemangioma variantBenignPedunculated lesion; bleeds easily; associated with trauma, pregnancy
Glomus tumorGlomus body (AVS)BenignPainful subungual lesion; benign
Kaposi SarcomaEndothelial (HHV-8)Intermediate/malignantAssociated with HIV/AIDS + HHV-8; spindle cell fascicles; slit-like vascular spaces
AngiosarcomaMalignant endothelialMalignantAssociated with: radiation, vinyl chloride (liver KS), chronic lymphedema (Stewart-Treves). Hemorrhagic nodules; poor prognosis
HemangiopericytomaPericytesIntermediateRare; "staghorn" vessels on histology


PART III: INTEGRATED CLINICAL CORRELATIONS


FLOWCHART A: Chest Pain - Differential Diagnosis Approach

ACUTE CHEST PAIN
        ↓
ECG ← →  12-lead ECG + Troponin + CXR
        ↓
┌─────────────────────┬───────────────────────┐
ST Elevation          Normal ECG +            Pleuritic pain
(STEMI)               Rising Troponin         (worse with inspiration)
    ↓                 (NSTEMI/UA)                    ↓
Emergent             Anti-ischemic Rx        Pulmonary embolism?
PCI/thrombolysis     + Cath within 24-72h    Pericarditis?
                                             Pneumonia?
└─────────────────────────────────────────────┘
  Also consider: Aortic dissection (tearing, ± unequal BP)
                 PE (sudden dyspnea, hypoxemia)
                 Tension pneumothorax (absent breath sounds)

FLOWCHART B: Pathophysiology of Left-Sided Heart Failure

LV Systolic/Diastolic Dysfunction
            ↓
        ↑ LV EDP (end-diastolic pressure)
            ↓
        ↑ LA pressure → ↑ Pulmonary venous pressure
            ↓
    ↑ Pulmonary capillary hydrostatic pressure
            ↓
    Fluid transudation into alveoli (pulmonary edema)
            ↓
    Dyspnea, orthopnea, PND, crackles, frothy sputum
            ↓         ↓
    Chronic:         Forward failure:
    Hemosiderin-     ↓ CO → fatigue, ↓ exercise
    laden macroph.   tolerance, prerenal azotemia
    ("HF cells")     cool extremities
    Brown induration
    of lungs
            ↓
    ↑ Pulmonary arterial pressure (reactive) → RV overload
            ↓
    RIGHT-SIDED HEART FAILURE
    (Peripheral edema, JVD, ascites, hepatomegaly)

TABLE: High-Yield Comparison - Major Cardiomyopathies

DilatedHypertrophicRestrictiveArrhythmogenic (ARVC)
ChamberAll 4 dilatedLV hypertrophy ± LVOTOAll 4, normal sizeRV fatty replacement
WallThin, flabbyThick, heavyRigid, non-compliantAneurysms, fibrofatty
EF↓↓ (<40%)↑ or normalNormal or ↓↓ RV function
Key geneTTN, LMNAMYH7, MYBP-CTTR (amyloid), GAA (Pompe)Desmoplakin, PKP2
SCD riskModerateHIGH (young athletes)ModerateHIGH (esp. athletes)
TreatmentGDMT + ICDMyectomy/mavacamten/ICDTreat causeICD, avoid sport

TABLE: ECG Changes in Key Conditions

ConditionECG Findings
HyperkalemiaPeaked T waves → wide QRS → sine wave → VF
HypokalemiaFlat T waves, U waves, prolonged QU
HypercalcemiaShort QT
HypocalcemiaProlonged QT
STEMI (anterior)ST elevation V1-V4 (LAD)
STEMI (inferior)ST elevation II, III, aVF (RCA)
STEMI (lateral)ST elevation I, aVL, V5-V6 (LCx)
LBBBBroad QRS + RSR' pattern V6; QS V1-V2
RBBBBroad QRS + RSR' ("rabbit ears") V1; S wave in V6
PericarditisDiffuse saddle-back ST elevation + PR depression
PES1Q3T3; sinus tachycardia; RBBB; right heart strain
Digoxin"Reverse tick" ST depression; short QT; AV block
WPWDelta wave, short PR, broad QRS

TABLE: Key Cardiac Enzymes, Biomarkers, and Clinical Use

MarkerRisePeakSensitivitySpecificityUse
Troponin I/T (hs)1-3 hr12-48 hrVery highHigh (cardiac specific)Diagnosis + prognosis of MI
CK-MB4-8 hr18-24 hrModerateModerateReinfarction (returns to normal faster)
BNP/NT-proBNPHours-High for HFModerateDiagnosis/prognosis of heart failure
Myoglobin1-2 hr4-8 hrHigh (early)LowEarly rule-out; not cardiac-specific
CRP (hs)Days-ModerateLowRisk stratification for atherosclerosis
LDH24 hr3-6 daysModerateLowHistorical

SUMMARY: HIGH-YIELD FACTS FOR EXAMINATIONS

  1. Frank-Starling Law: The heart pumps whatever blood it receives; EDV is the main determinant of stroke volume under normal conditions.
  2. Coronary Flow: 75% occurs in diastole; subendocardium is most vulnerable to ischemia.
  3. Action Potential Plateau (Phase 2): Due to L-type Ca²⁺ channels; responsible for long refractory period → prevents cardiac tetanus; absent in nodal cells.
  4. Irreversible MI injury: >20-30 minutes of ischemia; coagulative necrosis; troponin release.
  5. MI Morphology Timeline: Wavy fibers (0.5-4 hr) → coagulative necrosis + neutrophils (1-3 days) → macrophages + granulation tissue (3-7 days) → scar (>2 months).
  6. Most common cause of MI: Rupture of a non-critically stenosed atherosclerotic plaque (<50% stenosis) → acute thrombosis.
  7. Vulnerable plaque: Thin fibrous cap, large lipid core, dense inflammation, high MMP activity.
  8. HCM: Autosomal dominant; gain-of-function sarcomere mutations; myocardial disarray on biopsy; leading cause of SCD in young athletes.
  9. DCM: Cytoskeletal protein mutations (TTN most common); dilated all 4 chambers; systolic dysfunction.
  10. Most common cause of mitral stenosis: Rheumatic heart disease (Aschoff bodies; molecular mimicry).
  11. Most common cause of mitral regurgitation (US): Mitral valve prolapse (myxomatous degeneration).
  12. AAA: Infrarenal; male smokers >50; repair if ≥5.5 cm; classic: painless pulsatile abdominal mass; rupture = surgical emergency.
  13. Aortic dissection Type A: Involves ascending aorta → surgical emergency; Type B → medical (BP control).
  14. Cardiac tamponade: Beck's triad = hypotension + JVD + muffled heart sounds; pulsus paradoxus >10 mmHg.
  15. Ventricular free wall rupture: Most common 3-7 days post-MI; hemopericardium → tamponade.
  16. Septic shock hallmark: Refractory vasodilation via NO; cytokine storm; high or normal CO (distributive); DIC.
  17. Virchow's Triad for Thrombosis: Endothelial injury + Stasis/turbulence + Hypercoagulability.
  18. Kaposi Sarcoma: HHV-8 + HIV; spindle cells + slit-like vessels.
  19. Cardiac pressure overload → concentric hypertrophy (sarcomeres added in parallel, thick wall); volume overload → eccentric hypertrophy (sarcomeres in series, cavity dilates).
  20. BNP (B-type natriuretic peptide): Released by stretched ventricles; gold standard test for heart failure diagnosis; ↑ in both HFrEF and HFpEF.

REFERENCES

Guyton and Hall Textbook of Medical Physiology (14th Edition)

(ISBN: 9780443111013)
ChapterTopicBlockKey Lines
Ch. 9Cardiac Muscle Physiology; Cardiac CycleBlock 13570-3727
Ch. 10Electrical Activity; SA Node; Conduction SystemBlock 2341-480
Ch. 11The ElectrocardiogramBlock 2~600-900
Ch. 20Cardiac Output; Venous Return; Frank-StarlingBlock 3352-614
Ch. 21Cardiac Output in Disease; Cardiogenic ShockBlock 3533-570
Ch. 17Local Control of Blood Flow; AutoregulationBlock 3-
Ch. 18Nervous Regulation of Circulation; BaroreceptorsBlock 3-
Ch. 19Dominant Role of the Kidneys in Long-Term RegulationBlock 3-
Ch. 22Cardiac FailureBlock 31313-1500
Ch. 23Coronary CirculationBlock 31017-1055

Robbins, Cotran & Kumar Pathologic Basis of Disease (10th Edition)

(ISBN: 9780443264528)
ChapterTopicBlockKey Lines
Ch. 2Cellular Responses to Stress; Ischemic InjuryBlock 11873-1885
Ch. 4Hemodynamics; Edema; Thrombosis; Embolism; ShockBlock 2296-756
Ch. 11Blood Vessels: Atherosclerosis; Aneurysms; VasculitisBlock 52764-3300
Ch. 12Heart: IHD; Heart Failure; Cardiomyopathies; Valvular DiseaseBlock 6430-2300

These notes integrate the physiological foundations from Guyton & Hall with the pathological mechanisms and clinical correlations from Robbins & Cotran, providing a complete framework for understanding the cardiovascular system from normal function to disease.

After completing all the information create a pdf adding coloured pages and related digram and flow charts like present in book of quick under standing

Reading File
Running Command

mkdir -p /home/daytona/workspace/cardio-pdf && echo "Directory ready"

Runn the command

This is a shared conversation. Sign in to Orris to start your own chat.